Title

Gene expression pattern in canine mammary osteosarcoma

Journal title

Polish Journal of Veterinary Sciences

Yearbook

2011

Issue

No 1

Authors

Pawłowski, K. ; Król, M. ; Majewska, A. ; Szyszko, K. ; Dolka, I. ; Motyl, T.

Divisions of PAS

Nauki Biologiczne i Rolnicze

Publisher

Polish Academy of Sciences Committee of Veterinary Sciences ; University of Warmia and Mazury in Olsztyn

Date

2011

Identifier

DOI: 10.2478/v10181-011-0002-2 ; ISSN 1505-1773

Source

Polish Journal of Veterinary Sciences; 2011; No 1

References

D Alessi (1997), Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B[alpha], Curr Biol, 7, 261, doi.org/10.1016/S0960-9822(06)00122-9 ; D Alessi (1998), 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro, Curr Biol, 8, 69, doi.org/10.1016/S0960-9822(98)70037-5 ; A Balendran (2000), Further evidence that 3-phosphoinositide-dependent protein kinase-1 (PDK1) is required for the stability and phosphorylation of protein kinase C (PKC) isoforms, FEBS Lett, 484, 217, doi.org/10.1016/S0014-5793(00)02162-1 ; M Bordeleau (2006), RNA-mediated sequestration of the RNA helicase eIF4A by pateamine A inhibits translation initiation, Chem Biol, 13, 1287, doi.org/10.1016/j.chembiol.2006.10.005 ; B Brinkhof (2006), Development and evaluation of canine reference genes for accurate quantification of gene expression, Anal Biochem, 356, 36, doi.org/10.1016/j.ab.2006.06.001 ; L Cen (2007), PDK-1/AKT pathway as a novel therapeutic target in rhabdomyosarcoma cells using OSU-03012 compound, Br J Cancer, 97, 785, doi.org/10.1038/sj.bjc.6603952 ; A Clark (2002), Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells, Mol Cancer Ther, 1, 707. ; M Cooper (2008), Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk, Cancer Res, 68, 10171, doi.org/10.1158/0008-5472.CAN-08-1827 ; B Etschmann (2006), Selection of reference genes for quantitative real-time PCR analysis in canine mammary tumors using the GeNorm algorithm, Vet Pathol, 43, 934, doi.org/10.1354/vp.43-6-934 ; F Gartner (1999), DNA measurement and immunohistochemical characterization of epithelial and mesenchymal cells in canine mixed mammary tumours: putative evidence for a common histogenesis, Vet J, 158, 39, doi.org/10.1053/tvjl.1998.0333 ; P Gresner (2009), Expression of selenoprotein-coding genes SEPP1, SEP15 and hGPX1 in non-small cell lung cancer, Lung Cancer, 65, 34, doi.org/10.1016/j.lungcan.2008.10.023 ; E Hellmen (1993), Prognostic factors in canine mammary tumors: a multivariate study of 202 consecutive cases, Vet Pathol, 30, 20, doi.org/10.1177/030098589303000103 ; E Hellmen (2000), Expression of different phenotypes in cell lines from canine mammary spindle-cell tumours and osteosarcomas indicating a pluripotent mammary stem cell origin, Breast Cancer Res Treat, 61, 197, doi.org/10.1023/A:1006410020384 ; M Król (2009), Transcriptomic profile of two canine mammary cancer cell lines with different proliferative and anti-apoptotic potential, J Physiol Pharmacol, 60, 95. ; M Król (2010a), Transcriptomic signature of cell lines isolated from canine mammary adenocarcinoma metastases to lungs, J Appl Genet, 51, 37, doi.org/10.1007/BF03195709 ; M Król (2010b), Transcriptomic "portraits" of canine mammary cancer cell lines with various phenotypes, J Appl Genet, 51, 169, doi.org/10.1007/BF03195725 ; J Le Good (1998), Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1, Science, 281, 2042, doi.org/10.1126/science.281.5385.2042 ; S Leibl (2006), Mammary NOS-type sarcoma with CD10 expression: a rare entity with features of myoepithelial differentiation, Am J Surg Pathol, 30, 450. ; R Levine (2002), Tumor suppressor PTEN is mutated in canine osteosarcoma cell lines and tumors, Vet Pathol, 39, 372, doi.org/10.1354/vp.39-3-372 ; Y Mamane (2004), eIF4E - from translation to transformation, Oncogene, 23, 3172, doi.org/10.1038/sj.onc.1207549 ; M Maurer (2009), 3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma, Cancer Res, 69, 6299, doi.org/10.1158/0008-5472.CAN-09-0820 ; H Mi (2005), The PANTHER database of protein families, subfamilies, functions and pathways, Nucleic Acids Res, 33. ; A de los Monteros (2005), Expression of maspin in mammary gland tumors of the dog, Vet Pathol, 42, 250, doi.org/10.1354/vp.42-3-250 ; A Mora (2004), PDK1, the master regulator of AGC kinase signal transduction, Semin Cell Dev Biol, 15, 161, doi.org/10.1016/j.semcdb.2003.12.022 ; A Nesterov (2001), Elevated AKT activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis, J Biol Chem, 276, 10767, doi.org/10.1074/jbc.M005196200 ; C Page (2000), Overexpression of Akt/AKT can modulate chemotherapy-induced apoptosis, Anticancer Res, 20, 407. ; K Pawłowski (2009), Comparison of cellular and tissue transcriptional profiles in canine mammary tumor, J Physiol Pharmacol, 60, 85. ; S Pilar (2005), Therapeutic targeting of the Hedgehog-GLI pathway in prostate cancer, Cancer Res, 65, 2990. ; K Polyak (2007), Breast cancer: origins and evolution, J Clin Invest, 117, 3155, doi.org/10.1172/JCI33295 ; N Rao (2008), cDNA microarray profiles of canine mammary tumor cell lines reveal deregulated pathways pertaining to their phenotype, Anim Genet, 39, 333, doi.org/10.1111/j.1365-2052.2008.01733.x ; N Rao (2009), Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors, J Physiol Pharmacol, 60, 73. ; G Rogers Jr (2001), Modulation of the helicase activity of eIF4A by eIF4B, eIF4H, and eIF4F, J Biol Chem, 276, 30914, doi.org/10.1074/jbc.M100157200 ; M Sobczak-Filipiak (2002), Estrogen receptors in canine mammary gland tumours, Pol J Vet Sci, 5, 1. ; B Stecca (2007), Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways, Proc Natl Acad Sci USA, 104, 5895, doi.org/10.1073/pnas.0700776104 ; B Stecca (2010), Context-dependent regulation of the GLI code in cancer by HEDGEHOG and non-HEDGEHOG signals, J Mol Cell Biol, 2, 84, doi.org/10.1093/jmcb/mjp052 ; D Stokoe (1997), Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B, Science, 277, 567, doi.org/10.1126/science.277.5325.567 ; S Trent (2007), Heat shock protein B8, a cyclin-dependent kinase-independent cyclin D1 target gene, contributes to its effects on radiation sensitivity, Cancer Res, 67, 10774, doi.org/10.1158/0008-5472.CAN-07-1475 ; B Vogelstein (2004), Cancer genes and the pathways they control, Nat Med, 10, 789, doi.org/10.1038/nm1087 ; H Wensman (2009), Extensive expression of craniofacial related homeobox genes in canine mammary sarcomas, Breast Cancer Res Treat, 118, 333, doi.org/10.1007/s10549-008-0243-7 ; Z Xie (2003), Transformation of mammary epithelial cells by 3-phosphoinositidedependent protein kinase-1 activates beta-catenin and c-Myc, and down-regulates caveolin-1, Cancer Res, 63, 5370. ; Z Xie (2006), 3-phosphoinositide-dependent protein kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases, BMC Cancer, 6, 77, doi.org/10.1186/1471-2407-6-77 ; X Zeng (2002), Transformation of mammary epithelial cells by 3-phosphoinositide-dependent protein kinase-1 (PDK1) is associated with the induction of protein kinase C alpha, Cancer Res, 62, 3538. ; M Zeynep (2008), Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors, Mol Endocrinol, 22, 2116, doi.org/10.1210/me.2008-0059